The trademark application THERASURE was filed by Oncocyte Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on April 12, 2022, and it was registered by office on July 20, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in cancer therapy evaluation and transplantation monitoring and transplantation therapy evaluation.